Japan Opioid Induced Constipation Drugs Market was valued at USD 1.1 Billion in 2022 and is projected to reach USD 1.8 Billion by 2030, growing at a CAGR of 6.8% from 2024 to 2030.
The opioid-induced constipation (OIC) drugs market in Japan has witnessed significant growth due to the rising number of opioid prescriptions in the country. Opioid medications, commonly used to manage chronic pain, unfortunately, come with side effects, one of the most common being constipation. This has led to an increased demand for opioid-induced constipation drugs, which help manage the debilitating condition associated with opioid use. The OIC drugs market in Japan is primarily driven by the increasing awareness among patients and healthcare professionals about the availability of treatments that can mitigate the discomfort of OIC.
Opioid-induced constipation drugs can be classified into different types based on their mechanisms of action. These include laxatives, opioid antagonists, and peripherally acting mu-opioid receptor antagonists (PAMORAs). Laxatives are commonly used as the first line of treatment, while PAMORAs, such as methylnaltrexone, are often prescribed for patients who do not respond to traditional laxatives. The choice of treatment depends on the severity of the symptoms and the patient’s overall health condition. In Japan, the demand for PAMORAs has been on the rise due to their specific targeting of opioid receptors in the gut, offering a more direct and effective solution for OIC.
The opioid-induced constipation drugs market in Japan is not only influenced by the healthcare sector but also by pharmaceutical industries that constantly innovate to improve the quality and efficiency of these treatments. As the number of opioid prescriptions continues to grow, the requirement for specialized OIC drugs also increases, leading to collaborations between pharmaceutical companies and healthcare providers. This cooperation ensures the availability of advanced solutions tailored to the needs of patients who suffer from OIC.
Another key driver in the market is the growing elderly population in Japan. Older adults are particularly vulnerable to OIC due to the increased use of opioids for managing chronic pain conditions such as arthritis and cancer. Consequently, this demographic has created a substantial demand for effective opioid-induced constipation drugs in the market.
In addition to healthcare professionals’ recommendations, patients are becoming more proactive in seeking treatment for opioid-induced constipation. Pharmaceutical companies are responding by developing new formulations, such as oral tablets, injectables, and even subcutaneous medications, to cater to the diverse needs of patients.
The opioid-induced constipation drugs market is expected to continue expanding as the need for managing opioid-induced constipation grows in Japan’s aging population. As more effective treatments are introduced, the market will likely see an increase in competition, which could lead to further improvements in drug efficacy and patient outcomes.
Get an In-Depth Research Analysis of the Japan Opioid Induced Constipation Drugs Market Size And Forecast [2025-2032]
Â
Ironwood Pharmaceuticals Inc Daiichi Sankyo Co Ltd
Pfizer
Progenics Pharmaceuticals Inc Shionogi & Co.
Ltd
Allergan Plc
Nektar Therapeutics
Purdue Pharma
S.L.A. Pharma AG
Mundipharma International Limited
Ono Pharmaceutical Co.
Ltd
Takeda Pharmaceutical Company Limited
Theravance Biopharma Inc Valeant Pharmaceuticals International
Cosmo Pharmaceuticals SA
Daewoong Pharmaceutical
C.B. Fleet Company
Sucampo Pharmaceuticals
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Japan Opioid Induced Constipation Drugs Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Japan Opioid Induced Constipation Drugs Market
Anti-Reflective Coatings
Reflective Coatings
Beam Splitters
Filters
Polarizers
Vacuum Deposition
Sputtering
Electron Beam Evaporation
Chemical Vapor Deposition (CVD)
Ion Beam Sputtering
Consumer Electronics
Automotive
Aerospace and Defense
Healthcare
Telecommunications
Glass
Plastic
Metals
Quartz
Ceramics
Optical Manufacturers
Electronic Manufacturers
Automotive Manufacturers
Medical Device Manufacturers
Research Institutions
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
For More Information or Query, Visit @ Japan Opioid Induced Constipation Drugs Market Research Analysis
1. Introduction of the Japan Opioid Induced Constipation Drugs Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Japan Opioid Induced Constipation Drugs Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Japan Opioid Induced Constipation Drugs Market, By Type
6. Japan Opioid Induced Constipation Drugs Market, By Application
7. Japan Opioid Induced Constipation Drugs Market, By Geography
Asia-Pacific
China
Japan
Korea
India
Australia
Indonesia
Thailand
Philippines
Malaysia and Vietnam
8. Japan Opioid Induced Constipation Drugs Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/